Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Steven C. Moore

Matched on ORCID iD 0000-0002-8169-1661; OpenAlex author ID A5091281907, A5121011073. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 2, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

1998: 1 trial · 1999: none · 2000: none · 2001: none · 2002: none · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers · 2026: 6 papers

Papers 13

  1. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Co-author DOI 10.1007/s10654-026-01418-x↗
  2. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  3. Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk. First author DOI 10.1093/aje/kwag055↗
  4. Lipid biomarkers of habitual alcohol intake and associations with pancreatic cancer risk. Co-author DOI 10.1093/jnci/djaf288↗
  5. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  6. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  7. Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts. First author DOI 10.1002/ijc.35479↗
  8. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  9. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  10. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  11. Lipidomics and pancreatic cancer risk in two prospective studies. Co-author DOI 10.1007/s10654-023-01014-3↗
  12. Nested Case-Control Studies Investigating Serum Perfluorooctanoate and Perfluorooctane Sulfonate Levels and Pancreatic Ductal Adenocarcinoma in Two Cohorts. Co-author DOI 10.1289/ehp13208↗
  13. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study. Co-author DOI 10.1136/gutjnl-2019-319811↗

Trials 1

  1. Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial Principal investigator NCT00339495↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Demetrius Albanes · 6 shared papers, 2020–2026 · strength 1.42
  2. Rachael Z. Stolzenberg‐Solomon · 6 shared papers, 2020–2026 · strength 1.42
  3. Stephanie J. Weinstein · 5 shared papers, 2020–2026 · strength 1.21
  4. Ting Zhang · 4 shared papers, 2023–2026 · strength 1.08
  5. Sabine Naudin · 2 shared papers, 2023–2026 · strength 0.52
  6. Herbert Yu · 2 shared papers, 2023–2025 · strength 0.47
  7. Joshua Neil Sampson · 2 shared papers, 2020–2023 · strength 0.34
  8. Paloma R. Mitra · 1 shared paper, 2026 · strength 0.32
  9. Mark P. Purdue · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.